The Validation Summary Is Where the Evidence Becomes a Decision

Lukas
By

A summary should help a reviewer understand the scope, the result and the basis for acceptance. Repeating the names of completed documents does little to explain the significance of the work.

Reconnect the result to intended use

State the system, relevant version and accepted scope. Identify important exclusions and the reason they are outside the decision. The reader should not need to infer whether the report covers an entire platform, one configured workflow or a specific change.

For a hypothetical reporting application, the summary might cover a revised calculation and its dependent reports. It should distinguish that scope from unrelated functions that were not reassessed. Precision protects both the value and the limits of the conclusion.

Explain exceptions in decision terms

Summarize significant failures, deviations and corrective work with links to the supporting records. Explain why the final evidence is sufficient or which conditions remain before acceptance. A table of closed issue counts is less useful than a clear account of the issues that could affect intended use.

If a requirement was addressed through an alternative assurance activity, describe the rationale and evidence. If no additional execution was needed for part of the scope, point to the approved assessment supporting that decision. The summary should make the reasoning visible without reproducing every source document.

Keep AI assistance within the evidence

AI can help assemble a draft from controlled records and identify missing sections. Reviewers should check every substantive statement against its source. The draft must not turn an open issue into a resolved one, infer an approval that did not occur or claim broader coverage than the underlying evidence supports.

Validfor’s catalogue connects test results, exceptions and approvals within the lifecycle. Its test management and repository create a practical basis for preparing a summary from controlled records. The appealing outcome is less reconstruction and a clearer account of what the evidence actually supports.

A strong summary preserves the limitations that matter while making the decision easy to follow. It should remain useful to someone reviewing the package months later.

In recent years, validation processes across the pharmaceutical industry have been undergoing a major transformation. Workflows that were traditionally managed through paper documentation, spreadsheets and manual review cycles are increasingly moving toward digital validation platforms. As a result, life sciences organizations often evaluate solutions such as Kneat, Validfor, ValGenesis, MasterControl and Veeva when modernizing validation lifecycle management and compliance documentation.

Share This Article